Monday, November 30, 2015

The Most Common Causes of Eye Injuries in the US

In the past the most common causes of eye injuries was 4th of July fire crackers, baseball injuries or racketball injuries. Today the incidence of those causes have almost been eliminated by prevention. Most localities ban fireworks, the use of protective  eye wear in  sports, and in occupations has almost completely eliminated eye injuries from  those sources.

Falling was the No. 1 cause of eye injuries overall and accounted for more than 8,425 hospitalizations. Researchers also found that the cost to treat eye injuries at hospitals rose by 62 percent during that period and now exceeds $20,000 per injury.

Serious ocular trauma injuries include orbital fractures and being pierced by objects. These injuries can be expensive to treat, and in many cases are preventable. With that in mind, researchers at Johns Hopkins University decided to identify the most common causes of eye injuries as well as the associated hospital costs so that prevention efforts could be better targeted. Such interventions could perhaps lower eye injury rates and overall health care costs for eye trauma inpatient visits.
They identified a sample of nearly 47,000 patients ages 0 to 80 diagnosed with ocular trauma from 2002 to 2011 using a national health care database. They examined the total cost of hospitalization, cause of injury, type of injury and length of hospital stay. The researchers then grouped injured people by age. Their findings include:
•Falls are the leading cause of eye injury:

Most of the 8,425 falls recorded happened to those 60 and older. Among the types of falls, slipping caused nearly 3,000 eye injuries. Falling down stairs was cited as a cause of eye injury 900 times. 


•Fighting was second most common cause of ocular trauma:

 In total, nearly 8,000 hospitalizations for eye injuries were caused by fighting and various types of assault. 

“Unarmed fight or brawl” came in at No. 2 overall among specific causes of eye injuries requiring hospitalization, but was the top cause reported for ages 10 to 59.


•Kids injured in accidents, vehicle collisions and by sharp objects:

 For children ages 10 and under, the leading cause of eye injury was being struck by accident by a person or object. Car crashes and accidentally being pierced or cut by a sharp object (such as scissors) were second and third on the list of causes.

•The median cost of treating these eye injuries shot up from $12,430 to $20,116 between the years 2002 to 2011, an increase of 62 percent. The researchers found costs to be higher at large hospitals and for older patients. Income did not correlate with costs. However, the Johns Hopkins team says that other factors not included in the study could play a role, too.   More...

It is recommended that you wear protective eye wear when fighting, sanding metal, and other objects, playing baseball, or racketball, and target practice, 















The Most Common Causes of Eye Injuries in the US

Wednesday, November 25, 2015

Kaiser program brings hospital care to the patient's home

Who says primary care is dead?  It is just relocating....house-calls of the 21st Century


Audio from this story

Frequent medical visits had become a way of life earlier this year for John and Audrey Stanton of Hemet in Riverside County.  
John, 86, suffered from serious eye problems; a painful skin infection called cellulitis, and more recently, repeated shortness of breath — all of which kept landing him in the hospital."It was one thing after another. Like the doctor said, 'Somebody is after you!'" Stanton laughs. And for his 81-year-old wife Audrey, the nearly two-hour drive to-and-from Kaiser in Riverside was a tough haul."I’m not a long distance driver so I had to be real careful," she says. "It was stressful." 
But that stress dissipated last summer when John was admitted to the hospital — at home.  
"I thought, 'Wow! This is amazing. I love this!'" he says. "This is what people need!"

Pneumonia, cellulitis or congestive heart failure  Stanton is one of about 125 patients who’ve been enrolled in an experimental hospital at home program run out of Kaiser’s Permanente’s Riverside Medical Center.  Launched two years ago, the program is designed for people who need treatment - typically only given in the hospital — for one of three conditions: pneumonia, cellulitis or congestive heart failure.

"Our goals are to have patients be safe at home and to have them recover at home and to have a high-quality experience," says Dr. Earl Quijada, one of three Kaiser doctors assigned to the program. Not every patient with one of the three conditions qualifies for the program. It's restricted to those who are not at risk for complications that could require more intensive care, says Dr. Nirav Shah, senior vice president and chief operating officer for clinical operations at Kaiser Permanente Southern California. 
"We ask if that patient wants to be admitted [to the hospital] or admitted at home," Shah says. "If they choose to be admitted at home, we'll send a truck home with them with all the equipment they need."
For John Stanton, the program saved two to three days in the hospital as well as a number of return trips for follow-up visits, Quijada says.   

"Things are just so much more relaxed"

Stanton’s at-home care for a pneumonia diagnosis involved an intravenous antibiotic; a phlebotomist to check his blood and house calls from a nurse and Quijada. Hospital rounds — usually done by the patient's health care team in the hallway outside the patient's room — took place instead on the phone. 

Kaiser program brings hospital care to the patient's home 

Tuesday, November 24, 2015

The Affordable Care Act is it Working ?


If you are a Republican chances are very good you say  Obamacare (ACA) is a failure. If you are a Democrat you talk about its successes. The corollary is if you don't like Obamacare you are a Republican and if you like it you are a Democrat.
Which came first is like the chicken and the egg conundrum.

Obamacare is entering it's third year of transition.  Some pundits have it as entering a holding area to be monitored as some of it's vital organ systems are struggling to survive.

The ACA was passed during a political firestorm, and a majority Democratic congress. The only people who knew what was written in the statute were those who wrote the actual Bill. Some prominent Democrats overtly expressed "you won't know what is in it until we pass it".  Enough time has passed that we know that to be  true, but we also don't know what is coming next.

The health landscape has changed dramatically in the past decade as has the economy. The calculus has changed in regard to reimbursement models and organizational stability.

Several things are happening that should set off warning bells (if congress even listens or cares) in the middle of world crises.

Politics and health care have been mixed,and patients now find their health is competing with ISIS, the war on terror and everything in the national budget.  Physicians have always known and saw this several decades ago in 1963 when Medicare was added to social security entitlements..  As health expenses were met with an 80% coverage, and with  the lack of cost containment  medicare fueled health inflation. For more than two decades health expenditures grew at more than twice the rate of the gross domestic product, fueled by the black hole of the federal government and it's ability to manipulate budgets by borrowing and printing more currency.  Now it is a part of the seventeen trillion dollar national debt. Annually health contributes to 17% of the GDP.

The ACA went into effect in 2013 and beginning then there have been enormous changes in health care financing, the administration and delivery of medical care.

Health insurance companies,  health plans, and related enterprises such as pharma are adjusting to the limitations on profitability for operations.

Mergers and acquisitions have long been part and parcel of the health business scene. However the rate and size of the shifting health space has increased in numbers and size.

Health care business will survive in this hostile environment, as a necessity of life, the demand for services is infinite. The balance between restricting necessary health care and it's availability is precarious


Aetna, Anthem reassure investors on forecast, exchanges   
Pfizer, Allergan announce $160 billion merger, 'inversion' deal would shift HQ overseas

LAO Finds Rapid Medi-Cal Enrollment

Some insurers are treading lightly and reassessing their involvement in health insurance exchanges

Sunday, November 22, 2015

How Do Oncologists Use Social Media, and What Information Are They Seeking? | ASCO Connection

A new study in the Journal of Oncology Practice (JOP), explores how oncologists use social media. The study, “Social Media Use Among Physicians and Trainees: Results of a National Medical Oncology Physician Survey,” sheds light on the kind of professional knowledge clinicians seek when visiting sites such as Twitter and Facebook and identifies barriers to using social media. 
The study, published online, ahead of print, October 6, was carried out by a team of researchers from cancer centers across Canada and was designed to address a gap in the research: nearly all previous studies on the nexus of social media and medicine have focus on the challenges social media presents in terms of privacy and maintaining professionalism.
”The existing literature on social media was really just cautioning doctors, and wasn’t focusing on the opportunities social media was presenting,” said Rachel Adilman, BSc, first author of the study. “We wanted to highlight the fact that social media actually has opportunities for us. We can share knowledge, we can collaborate, and we can harness these opportunities to further our knowledge and cooperation.”
How are oncologists using social media?
The researchers sent surveys to 680 medical, radiation, and surgical oncologists; hematologists; and oncology trainees, asking about different aspects of social media use; Trainees were defined as pre-medical students, medical students, and residents. Two hundred and seven study participants sent back the surveys (a response rate of 30%). Analysis of the responses revealed these findings:
  • Frequency of social media use: 72% of respondents use social media
     
  • Differences in use of social media by age of oncologist: The study used age as an indicator of respondent’s career phase, whether trainees, fellows, or early-, mid-, or late-career oncologists. Among those age 18-24 (trainees) and 25-34 (fellows), 89% and 93%, respectively, use social media. However, among those age 35-44 (early-career), the percentage goes down to 72%. And among those age 45-54 (mid-career), the percentage of oncologists who use social media dips down to 39%, a rate that is significantly lower than the 89% and 93% seen among trainees and fellows. Interestingly, late-career oncologists (age 55 and over) have a higher rate of social media use (59%) compared to mid-career oncologists.
     
  • What are oncologists’ goals in visiting social media sites for professional development?
Fifty five percent of respondents said their goal in visiting social media sites was to network with colleagues or professionals, 17% said their goal was to share research, and 13% said their goal was leadership development.
When separated by age group, differences emerged between users’ goals in visiting social media sites. Among the trainees and early-career cohorts, more than 53% of respondents reported a desire for professional networking, whereas among mid-career oncologists, the rate was 36%.
  • What kind of professional information are oncologists seeking on social media sites?
Fifty three percent of respondents said they are seeking journal articles, 52% said they are seeking information about upcoming conferences and courses, and 51% are looking for updates on current oncology research.
 Search features on  all social media platforms allow users to search using a # hashtag. In essence this turns twiiter into a search engine for diseases, conferences, and specialty or other term of interest.





How Do Oncologists Use Social Media, and What Information Are They Seeking? | ASCO Connection

The Future of Work: Quantified Employees, Pop-Up Workplaces, And More Telepresence







The Future of Work: Quantified Employees, Pop-Up Workplaces, And More Telepresence

The 10 Most Important Work Skills in 2020














The 10 Most Important Work Skills in 2020

CDC’s Health IQ App | Mobile Activities | CDC

INFOGRAPHIC: Electronic Health Records History | Patients & Families | HealthIT.gov









INFOGRAPHIC: Electronic Health Records History | Patients & Families | HealthIT.gov

What Patients need to know about EHR and HIT

Putting the I in Health IT




This video provides inspiring patient testimonials and informational interviews with representatives from the government on how health IT makes a difference in consumers' lives.


Ensuring the Security of Electronic Health Records Video:



It is vital to do as much as possible to protect sensitive health information in EHRs. Find out more about how providers are keeping individual health information safe and secure through cybersecurity.

Health IT Stories:
The best way to understand the value of health IT can be through personal testimonials from consumers and patients who have personal experiences using it to improve their health and health care. These videos are a small excerpt which represent many personal stories of consumers using e-Health and health IT tools to manage their care.

I’ve Seen the Disaster Averted”  

Dottie Bringle, R.N., is a hospital executive in Joplin, MO. Three weeks before Joplin's devastating tornado in May 2011, her hospital completed a switch to an EHR – so even though her hospital building was destroyed, doctors and nurses were able to provide care to Joplin residents in their time of need.

Lilianne Wright, upon hiking in the Grand Canyon, suffered from severe stages of diabetic ketoacidosis, which brought her to the brink of death. Ms. Wright recovered, but found that managing her disease was and still is complicated, because her doctors can't easily share her medical records. Today, her two children are reaping the benefits of EHRs.

A stage 4 kidney cancer survivor, Dave de Bronkart has learned first-hand that good health care depends on good information. Now he blogs as "e-patient Dave," writing about how health information technology and electronic health records can improve health care by empowering patients to access their health information and take an active role in their own care. This is his story.
Health IT, Advancing America's Health Care  pdf download



Saturday, November 21, 2015

Are You Depressed ? Take a Motrin

Depression has been linked to many other illnesses, genetics, lack of certain vitamins, poor nutrition, lack of exercise and more. 

About one third of people with depression have high levels of inflammation markers in their blood. New research indicates that persistent inflammation affects the brain in ways that are connected with stubborn symptoms of depression, such as anhedonia, the inability to experience pleasure.

The results were published online on Nov. 10 in Molecular Psychiatry.
The findings bolster the case that the high-inflammation form of depression is distinct, and are guiding researchers' plans to test treatments tailored for it.
Anhedonia is a core symptom of depression that is particularly difficult to treat, says lead author Jennifer Felger, PhD, assistant professor of psychiatry and behavioral sciences at Emory University School of Medicine and Winship Cancer Institute.
"Some patients taking antidepressants continue to suffer from anhedonia," Felger says. "Our data suggest that by blocking inflammation or its effects on the brain, we may be able to reverse anhedonia and help depressed individuals who fail to respond to antidepressants."
In a study of 48 patients with depression, high levels of the inflammatory marker CRP (C-reactive protein) were linked with a "failure to communicate", seen through brain imaging, between regions of the brain important for motivation and reward.
High CRP levels were also correlated with patients' reports of anhedonia: an inability to derive enjoyment from everyday activities, such as food or time with family and friends. Low connectivity between another region of the striatum and the  was linked to a different symptom: slow motor function, as measured by finger tapping speed.
As a next step, Felger is planning to test whether L-DOPA, a medicine that targets the brain chemical dopamine, can increase connectivity in reward-related  regions in patients with high-inflammation depression. This upcoming study is being supported by the Dana Foundation.
Felger's previous research in non-human primates suggests that inflammation leads to reduced dopamine release. L-DOPA is a precursor for dopamine and often given to people with Parkinson's disease.










Inflammation linked to weakened reward circuits in depression

Thursday, November 19, 2015

In 5 Minutes, He Lets the Blind See - The New York Times

HETAUDA, Nepal — WATCHING the doctor perform is like observing miracles.









A day after he operates to remove cataracts, he pulls off the bandages — and, lo! They can see clearly. At first tentatively, then jubilantly, they gaze about. A few hours later, they walk home, radiating an ineffable bliss.
Dr. Sanduk Ruit, a Nepali ophthalmologist, may be the world champion in the war on blindness. Some 39 million people worldwide are blind — about half because of cataracts — and another 246 million have impaired vision, according to the World Health Organization.
Dr. Sanduk Ruit, a Nepali ophthalmologist, may be the world champion in the war on blindness. Some 39 million people worldwide are blind — about half because of cataracts — and another 246 million have impaired vision, according to the World Health Organization.














In 5 Minutes, He Lets the Blind See - The New York Times

Monday, November 16, 2015

Rapper, Internist ZDoggMD on the 'Hard Doc's Life'

 In this segment of Medscape One-on-One, Editor-in-Chief Eric J. Topol, MD, interviews Zubin Damania, MD, a practicing internist who uses musical parody as a clinical teaching tool and to bring attention to the concerns facing practicing clinicians. Performing under the name ZDoggMD, Dr Damania has used music to broach many topics from conveying the need for a more humane approach to end-of-life care to the frustrations of using a less-than-intuitive electronic health record (EHR) system.

After spending 10 years in the "Hard Doc's Life" working as a hospitalist in the Silicon Valley, he was lured to Las Vegas by Zappos CEO Tony Hsieh, a former classmate of Dr Damania's wife. There, Dr Damania founded Turntable Health as part of Mr Hsieh's $350 million investment to revitalize downtown Las Vegas.






Rapper, Internist ZDoggMD on the 'Hard Doc's Life'

Sunday, November 15, 2015

Many Say High Deductibles Make Their Health Law Insurance All but Useless - The New York Times



 Obama administration officials, urging people to sign up for health insurance under the Affordable Care Act, have trumpeted the low premiums available on the law’s new marketplaces.
But for many consumers, the sticker shock is coming not on the front end, when they purchase the plans, but on the back end when they get sick: sky-high deductibles that are leaving some newly insured feeling nearly as vulnerable as they were before they had coverage.
“The deductible, $3,000 a year, makes it impossible to actually go to the doctor,” said David R. Reines, 60, of Jefferson Township, N.J., a former hardware salesman with chronic knee pain. “We have insurance, but can’t afford to use it.”

In many states, more than half the plans offered for sale through HealthCare.gov, the federal online marketplace, have a deductible of $3,000 or more, a New York Times review has found. Those deductibles are causing concern among Democrats — and some Republican detractors of the health law, who once pushed high-deductible health plans in the belief that consumers would be more cost-conscious if they had more of a financial stake or skin in the game.
“We could not afford the deductible,” said Kevin Fanning, 59, who lives in North Texas, near Wichita Falls. “Basically I was paying for insurance I could not afford to use.”
He dropped his policy.

Sylvia Mathews Burwell, the secretary of health and human services, issued a report analyzing premiums in the 38 states that useHealthCare.gov. “Eight out of 10 returning consumers will be able to buy a plan with premiums less than $100 a month after tax credits,” she said.
But in interviews, a number of consumers made it clear that premiums were only one side of the affordability equation.

Exceptions, waivers and options are not known by most ACA enrollees.
Tax Credits are a false incentive for many enrollees

Many are in a category with income low enough they do not pay taxes, however if they have withold from their payroll they would be entitle to a full refund of their witheld taxes.  However, these refunds do not become available until after the early months of the following year. For the initial year of enrollment there are no excess funds for tax credits.


Health officials and insurance counselors cite several mitigating factors. All plans must cover preventive services like mammograms and colonoscopieswithout a deductible or co-payment. Some plans may help pay for some items, like generic drugs or visits to a primary care doctor, before patients have met the deductible. Under the Affordable Care Act, health plans must have an overall limit on out-of-pocket costs, to protect people with serious illness against financial ruin.
In addition, people with particularly low incomes can obtain discounts known as cost-sharing reductions, which lower their deductibles and other out-of-pocket costs if they choose midlevel silver plans. Consumer advocates say this assistance makes insurance a good bargain for people with annual incomes from 100 percent to 250 percent of the poverty level ($11,770 to $29,425 for an individual).
Dave Chandra, a policy analyst at the liberal-leaning Center on Budget and Policy Priorities, has some advice: “Everyone should come back to the marketplace and shop. You may get a better deal.”

Friday, November 13, 2015

White House Details Privacy Rules for Precision Medicine Initiative - iHealthBeat



On Monday, the White House unveiled a series of privacy principlesfor President Obama's precision medicine initiative, FierceHealthITreports (Hall, FierceHealthIT, 11/11).

Initiative Details

In February, Obama in his fiscal year 2016 budget proposal asked Congress for $215 million in funding for a precision medicine initiative that centers on the creation of a massive database containing the genetic data of at least one million volunteer participants. A panel of experts in September endorsed the plan for creating the database (iHealthBeat, 9/18).

Details of the Privacy Principles

The privacy principles aim to protect the data of individuals participating in the precision medicine initiative. 




White House Details Privacy Rules for Precision Medicine Initiative - iHealthBeat

Thursday, November 12, 2015

No, Zeke, You’re Not Paying For My Medicine | Galen Institute

Zeke Emanuel is tired of paying for your expensive medicine.
Dr. Emanuel, who served in a senior position at the Office of Management and Budget where he contributed to the recurring nightmare known as ObamaCare, recently complained in the New York Times [“I Am Paying For Your Expensive Medicine”] that his insurance rates are high because the medicines you’re taking cost too much.
“We all need to care about not only our own health care bills but also those of our neighbors,” he writes.  And by caring about your neighbors’ bills, he means finding a way to avoid them.
What evidently provoked Dr. Emanuel to fret about your medical bills was something called a PCSK9 inhibitor, a recently approved class of biologics that, according to a preliminary study, reduces the risk of heart disease and stroke by half.
YOU may not know it, but you could be on the hook to pay at least $124 this year for a drug you probably don’t take.
The drug is a new class of cholesterol-lowering agents called PCSK9 inhibitors. Its cost and how we are paying for it illustrate why we all need to care about not only our own health care bills but also those of our neighbors. And it helps focus the debate about drug prices on two questions: What is the value delivered by the drug, and can that be linked to its price? And how should such value-based prices be implemented?

In July, the Food and Drug Administration approved the first of two new PCSK9 inhibitors that lower the bad type of cholesterol, LDL. Studies suggest that they can reduce it by up to 60 percent, compared with a placebo, and reduce it up to 36 percent more than statins and a drug called ezetimibe. However, there are no definitive data on how much these drugs actually reduce heart attacks, strokes and deaths from heart disease. 

Ethical concerns aside (should government determine how much an additional quality-year” of life (QUALY) is worth?), government policies have so distorted medical prices as to render the sorts of calculations Emanuel favors suspect.  Before considering whether to import England’s algorithm for determining value, policymakers would do well to reflect on the wreckage that previous government forays into the health care marketplace have wrought.
The government, for example, imposes price controls in the VA system.  It also operates aMedicaid “rebate” program, which requires drug makers to mark down the price of medicines in that burgeoning program.  It mandates similar price concessions to a growing list of clinics and hospitals.  Manufacturers also must slash prices by 50 percent for Medicare beneficiaries who have fallen into the drug benefit’s “donut hole.”
When the government requires manufacturers to provide steep discounts to such a broad swath of the market, they predictably charge higher prices to everyone else.
Emanuel doesn’t just overlook the distorting effect government actions have had on drug prices, but he also fails to see how government has deformed health insurance markets.  Federal programs have long divorced premiums from risk.  ObamaCare has extended that practice into the individual and small group markets, creating a program in which people who wait until they are sick to buy insurance pay the same rates as those who maintained continuous coverage when they were healthy.
It has thus made insurance a good deal for people who have pre-existing medical conditions and a bad deal for people who don’t.   That is a major reason why the vast majority of uninsured people in reasonably good health who don’t qualify for government premium and cost-sharing subsidies have so far chosen to remain uninsured.  It also helps explain how insurance companies have managed to lose money under the program, even after pocketing billions in corporate welfare payments.
The accretion of government intrusions into the health care marketplace has distorted medical prices beyond recognition.  Good intentions have motivated every intervention, each of which has engendered a new round of problems that, in turn, have inspired further well-meaning interventions.  The result is a costly and inefficient system where prices are unhinged from value.
Government is bad at paying for value.  For consumers, it is a core competency.  Instead of smoldering over other people’s medical bills, Emanuel would do well to devote his considerable intellect to scraping away regulatory barnacles that prevent price discovery.  Instead of more government, we need a health care system that functions like the rest of the economy where, as Emanuel put it, “individuals determine value.”
Doug Badger is a retired White House and U.S. Senate policy adviser and a Senior Fellow at the Galen Institute.


No, Zeke, You’re Not Paying For My Medicine | Galen Institute

Tuesday, November 10, 2015

Medicare blocks Research into Substance buse


HIPAA is interfering with legitimate research goals


In an eye-catching study last week, Nobel Prize for Economics, for 2015, winner Angus Deaton and his co-author Anne Case found that deaths among middle-aged white men are spiking — and concluded that alcohol and substance abuse are at least partly to blame.

The finding is "shocking," health care historian Paul Starr wrote at the American Prospect. "This midlife mortality reversal had no parallel in any other industrialized society or in other demographic groups in the United States."But here's an even bigger surprise: The federal agency that oversees the nation's largest trove of health data won't let researchers study the problem. 
In an unusual move, the Centers for Medicare and Medicaid Services in 2013 began quietly deleting substance use disorder data from the files they share with researchers. Up until that point, CMS had freely allowed researchers to use the data to track health care procedures related to substance use across millions of patients.

We know substance abuse deaths are rising. But Medicare won't let researchers study the problem.


Given our results, and the great interest in what is happening, it is clear that the removal of those data is particularly ill-timed, although I am sure it was done for legitimate reasons," Deaton says. "There is an enormous amount of stigma associated with addiction, and perhaps [CMS officials] were concerned about that. I don't know. But it certainly makes it harder to dig down into a vitally important question of social and health policy."

Wednesday, November 4, 2015

The remedy is to reimagine health

Sometimes the road to imaging health is to imagine disease. The vision of disease and/or death is striking. However health cannot be evaluated strictly by looking at a person.  We all have heard about people who look good, fit, are very active and who suddenly die. It leaves us all perplexed.  However careful appraisal and digging into details results that all is not what it  seems.




The Remedy is to Reimagine Health







The Affordable Care Act is similar to comparing disease and health.  It ain't what it seems. The ACA diverted most clinicians away from the essentials of modern medicine, the rapid technological advances that have occured and even more, that which is on the near horizon.


Healthcare Industry | Digital Revolution | Entrepreneurship | Innovation | The remedy is to reimagine health | Vision Magazine



Healthcare Industry | Digital Revolution | Entrepreneurship | Innovation | The remedy is to reimagine health | Vision Magazine

Medical Marijuana: No snake oil, but it may hold hope for some - AgingCare.com

Growing older is a bit like early childhood. Each day evolves differently.  It is a bit like childhood in reverse. As a child matures he gains some ability, in speech,  motor activity, cognition and emotional development.  The stages are all there.



As we age maturation appears to reverse itself, gradually at first, then more quickly.  The process is sensescence. We recognize some of this by cognitive changes, behavioral changes, physical changes, and at times the expression of infantile or emotional reactions of early youth.





Medical Marijuana: No snake oil, but it may hold hope for some - AgingCare.com

How Doctors Became Subcontractors | THCB



In our healthcare system, the “middleman” is not who you think



Your doctor no longer works for the patient, but to satisfy a payer.



It works like this. You, the patient pay a monthly premium in return for payment coverage to your physician. The requirements for payment are complicated, and if the physician does not meet these inflexible demands he is not paid ("Denied"). Often times there is no explanation.



This has been a gradual shift in doctor-patient relationship which has become the dominant model for reimbursement.  What this means essentially is that your doctor works not for you, but your insurer. You pay the premium for the insurer to reimburse a doctor of their choosing (see your provider directory) Often times your  doctor is part of a group practice and in a closed network.



It has been a pervasive cancerous expansion of limiting your access to care, and you are paying the insurance company to limit your freedom of access. It is part and parcel of the "Nanny State", one in which someone else is deciding what is good or bad for you, the patient.



It is not the only organization which uses the Nanny state approach. It is the means which Government now controls almost anything.Your freedoms are disappearing.



The Health Care Blog carries the important message from MICHEL ACCAD, MD, who says, In our healthcare system, the “middleman” is not who you think"







How Doctors Became Subcontractors | THCB